These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 37175798)
1. Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis. Papadimitriou E; Kanellopoulou VK Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175798 [TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase ζ enhances proliferation by increasing β-catenin nuclear expression in VHL-inactive human renal cell carcinoma cells. Shang D; Xu X; Wang D; Li Y; Liu Y World J Urol; 2013 Dec; 31(6):1547-54. PubMed ID: 23588815 [TBL] [Abstract][Full Text] [Related]
6. Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. McClain CR; Sim FJ; Goldman SA J Neurosci; 2012 Oct; 32(43):15066-75. PubMed ID: 23100427 [TBL] [Abstract][Full Text] [Related]
7. HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1. He ZC; Liu Q; Yang KD; Chen C; Zhang XN; Wang WY; Zeng H; Wang B; Liu YQ; Luo M; Li L; Niu Q; Lu HM; Luo T; Yao XH; Guo HT; Ji JL; Cao MF; Shi Y; Ping YF; Bian XW Cancer Lett; 2022 May; 533():215605. PubMed ID: 35219772 [TBL] [Abstract][Full Text] [Related]
8. A novel PTPRZ1-ETV1 fusion in gliomas. Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells. Huang P; Ouyang DJ; Chang S; Li MY; Li L; Li QY; Zeng R; Zou QY; Su J; Zhao P; Pei L; Yi WJ Cell Commun Signal; 2018 Nov; 16(1):92. PubMed ID: 30497491 [TBL] [Abstract][Full Text] [Related]
10. PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma. Makinoshima H; Ishii G; Kojima M; Fujii S; Higuchi Y; Kuwata T; Ochiai A BMC Cancer; 2012 Nov; 12():537. PubMed ID: 23170925 [TBL] [Abstract][Full Text] [Related]
11. High PTPRQ Expression and Its Relationship to Expression of PTPRZ1 and the Presence of KRAS Mutations in Colorectal Cancer Tissues. Laczmanska I; Karpinski P; Gil J; Laczmanski L; Bebenek M; Sasiadek MM Anticancer Res; 2016 Feb; 36(2):677-81. PubMed ID: 26851024 [TBL] [Abstract][Full Text] [Related]
12. MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth and invasion. Zhang F; Mai SR; Cao FP; Cao CX; Zhang L Hum Cell; 2019 Oct; 32(4):540-547. PubMed ID: 31364003 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions. Chen HM; Yu K; Tang XY; Bao ZS; Jiang T; Fan XL; Chen XW; Su XD FEBS Lett; 2015 Jun; 589(13):1437-43. PubMed ID: 25935522 [TBL] [Abstract][Full Text] [Related]
15. Receptor-Type Protein-Tyrosine Phosphatase ζ and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1. Zwicker S; Bureik D; Bosma M; Martinez GL; Almer S; Boström EA PLoS One; 2016; 11(11):e0167324. PubMed ID: 27898738 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha. Wang V; Davis DA; Veeranna RP; Haque M; Yarchoan R PLoS One; 2010 Mar; 5(3):e9641. PubMed ID: 20224786 [TBL] [Abstract][Full Text] [Related]
17. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer. Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. Takahashi N; Sakurai T; Bozdagi-Gunal O; Dorr NP; Moy J; Krug L; Gama-Sosa M; Elder GA; Koch RJ; Walker RH; Hof PR; Davis KL; Buxbaum JD Transl Psychiatry; 2011 May; 1(5):e8. PubMed ID: 22832403 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol. Fernández-Calle R; Vicente-Rodríguez M; Pastor M; Gramage E; Di Geronimo B; Zapico JM; Coderch C; Pérez-García C; Lasek AW; de Pascual-Teresa B; Ramos A; Herradón G Neuropharmacology; 2018 Jul; 137():86-95. PubMed ID: 29753117 [TBL] [Abstract][Full Text] [Related]
20. Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway. Liu YT; Shang D; Akatsuka S; Ohara H; Dutta KK; Mizushima K; Naito Y; Yoshikawa T; Izumiya M; Abe K; Nakagama H; Noguchi N; Toyokuni S Am J Pathol; 2007 Dec; 171(6):1978-88. PubMed ID: 18055543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]